<DOC>
	<DOCNO>NCT00938314</DOCNO>
	<brief_summary>The purpose study : - To assess neurological outcome acute ischemic stroke patient treat NTx®-265 , compare patient give placebo control . - To assess safety tolerability NTx®-265 give acute ischemic stroke patient .</brief_summary>
	<brief_title>Study NTx®-265 : Human Chorionic Gonadotropin ( hCG ) Epoetin Alfa ( EPO ) Acute Ischemic Stroke Patients</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Chorionic Gonadotropin</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Age 1885 NIHSS score 820 Stroke ischemic origin , supratentorial , radiologically confirm Patient 2448 hour time stroke onset first dose NTx®265 therapy administer Reasonable expectation availability receive full 9 day NTx® 265 therapy subsequent followup visit Reasonable expectation patient receive standard poststroke physical , occupational , speech , cognitive therapy indicate Female patient either childbearing potential agrees use two effective separate nonhormonal form contraception throughout study Patients present lacunar , hemorrhagic and/or brain stem stroke Patients receive tissue plasminogen activator ( tPA ) follow index stroke Patients classify comatose Women test positive pregnancy , breastfeeding , use birth control Serum hemoglobin &gt; 16 gram ( g ) /deciliter ( dL ) ( male ) &gt; 14 g/dL ( female ) ; platelet count &gt; 400,000/cubic millimeter ( mm3 ) Advanced liver , kidney , cardiac , pulmonary disease Elevated serum bilirubin , alkaline phosphatase , aspartate aminotransferase ( AST ) alanine transaminase ( ALT ) , creatinine , prostatespecific antigen ( PSA ) level Patients know history hypercoagulability Expected survival &lt; 1 year Allergy contraindication hCG EPO A known diagnosis cancer previous 5 year Uncontrolled hypertension Use either hCG epoetin alfa within previous 90 day Any condition know elevate hCG Patients prestroke/premorbid modify Rankin Score ( mRS ) ≥ 2 Any patient live independently Any medical condition degree stroke , investigator 's opinion , patient include trial With exception qualify stroke , stroke within previous 3 month Patients take antiplatelet anticoagulant therapy Preexisting active major psychiatric chronic neurological disease Alcohol abuse history substance abuse dependency within 12 month prior study Currently participate another investigational study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>